XML 23 R7.htm IDEA: XBRL DOCUMENT v3.4.0.3
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Cash flows from operating activities:    
Net income $ 69,191 $ 133,076
Adjustments to reconcile net income to net cash used in operating activities:    
Depreciation and amortization 14,109 11,311
Deferred tax expense (benefit) 33,270 (11)
Realized investment gains, net (3,056) (26,327)
Excess tax benefits related to share-based compensation (115) (2,568)
Payment of original issue discount-convertible junior subordinated debentures (41,540) 0
Change in certain assets and liabilities:    
Accrued investment income 1,205 (1,596)
Prepaid insurance premium 34 (2,496)
Reinsurance recoverable on loss reserves 3,368 2,426
Reinsurance recoverable on paid losses (536) 458
Premium receivable 1,284 (1,812)
Deferred insurance policy acquisition costs (705) (1,011)
Profit commission receivable 760 (23,474)
Loss reserves (140,013) (152,183)
Premium deficiency reserve 0 (6,418)
Unearned premiums 9,906 19,639
Return premium accrual (4,850) 3,300
Income taxes payable - current 289 287
Other 869 14,691
Net cash used in operating activities (56,530) (32,708)
Purchases of investments:    
Fixed maturities (288,273) (940,867)
Equity securities (3,109) (18)
Proceeds from sales of fixed maturities 315,927 795,968
Proceeds from maturity of fixed maturities 139,863 192,463
Proceeds from sale of equity securities 2,525 0
Net increase in payable for securities 44,289 699
Net decrease in restricted cash 0 17,212
Additions to property and equipment (1,916) (576)
Net cash provided by investing activities 209,306 64,881
Cash flows from financing activities:    
Proceeds from issuance of long-term debt 155,000 0
Purchase of convertible senior notes (138,253) 0
Purchase of convertible junior subordinated debentures-liability component (91,110) 0
Purchase of convertible junior subordinated debentures-equity component (9,750) 0
Excess tax benefits related to share-based compensation 115 2,568
Net cash (used in) provided by financing activities (83,998) 2,568
Net increase in cash and cash equivalents 68,778 34,741
Cash and cash equivalents at beginning of period 181,120 197,882
Cash and cash equivalents at end of period $ 249,898 $ 232,623